Literature DB >> 30008889

Migration and invasion in B16-F10 mouse melanoma cells are regulated by Nrf2 inhibition during treatment with ionizing radiation.

Yali Gao1, Zishen Zhao2, Xiaoyin Meng3, Hongguag Chen4, Guojun Fu2.   

Abstract

Nuclear factor erythroid 2-related factor 2 (Nrf2) serves a critical role in carcinogenesis. The present study examined the effect of Nrf2 on the proliferation and invasion of melanoma cells that were treated with ionizing radiation. B16-F10 mouse melanoma cells were exposed to various doses of ionizing radiation for different time periods. Small interfering (si)RNAs targeting Nrf2 were transfected into B16-F10 cells, and cell proliferation, invasion and apoptosis were detected by Transwell, MTT or western blot assays. The expression of Nrf2 and its downstream heme oxygenase 1 (HO-1) was analyzed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting. HO-1 activity was also examined. Ionizing radiation stimulated Nrf2 expression, increased caspase-3 expression, and reduced the viability, migration and invasion of B16-F10 mouse melanoma cells. Transfection with Nrf2 siRNA was able to inhibit Nrf2 and HO-1 expression in B16-F10 mouse melanoma cells that were treated by ionizing radiation. Inhibition of Nrf2 further reduced cell viability, invasion and migration, and elevated caspase-3 expression in B16-F10 mice melanoma cells that were treated by ionizing radiation. In summary, treatment with ionizing radiation was able to stimulate Nrf2 expression and regulate cell viability, invasion and migration of B16-F10 cells. A combination of Nrf2 knockdown and ionizing radiation treatment exerted a synergistic effect on migration, invasion and apoptosis in B16-F10 murine melanoma cells.

Entities:  

Keywords:  NF-E2-related factor 2; invasion; melanoma; migration; radiotherapy

Year:  2018        PMID: 30008889      PMCID: PMC6036499          DOI: 10.3892/ol.2018.8799

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.

Authors:  K L Streicher; W Zhu; K P Lehmann; R W Georgantas; C A Morehouse; P Brohawn; R A Carrasco; Z Xiao; D A Tice; B W Higgs; L Richman; B Jallal; K Ranade; Y Yao
Journal:  Oncogene       Date:  2011-08-22       Impact factor: 9.867

2.  Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells.

Authors:  Qiuyue Zhao; Aihong Mao; Jiawei Yan; Chao Sun; Cuixia Di; Xin Zhou; Hongyan Li; Ruoshui Guo; Hong Zhang
Journal:  Int J Oncol       Date:  2015-12-18       Impact factor: 5.650

3.  An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses.

Authors:  Saelooom Lee; Min-Jin Lim; Mi-Hyoung Kim; Chi-Ho Yu; Yeon-Sook Yun; Jiyeon Ahn; Jie-Young Song
Journal:  Free Radic Biol Med       Date:  2012-06-07       Impact factor: 7.376

4.  Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.

Authors:  L Serrone; M Zeuli; F M Sega; F Cognetti
Journal:  J Exp Clin Cancer Res       Date:  2000-03

5.  Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism.

Authors:  Dan Meng; Xin Wang; Qingshan Chang; Andrew Hitron; Zhuo Zhang; Mei Xu; Gang Chen; Jia Luo; Binghua Jiang; Jing Fang; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-18       Impact factor: 4.219

6.  Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma.

Authors:  Laura M Alwan; Kenneth Grossmann; Daniel Sageser; Joan Van Atta; Neeraj Agarwal; Jeffrey A Gilreath
Journal:  Target Oncol       Date:  2013-04-23       Impact factor: 4.493

7.  Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.

Authors:  Tatsuhiro Shibata; Tsutomu Ohta; Kit I Tong; Akiko Kokubu; Reiko Odogawa; Koji Tsuta; Hisao Asamura; Masayuki Yamamoto; Setsuo Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

Review 8.  Cytoprotection "gone astray": Nrf2 and its role in cancer.

Authors:  Claudia Geismann; Alexander Arlt; Susanne Sebens; Heiner Schäfer
Journal:  Onco Targets Ther       Date:  2014-08-26       Impact factor: 4.147

9.  Casticin Inhibits A375.S2 Human Melanoma Cell Migration/Invasion through Downregulating NF-κB and Matrix Metalloproteinase-2 and -1.

Authors:  Zih-Yun Wu; Jin-Cherng Lien; Yi-Ping Huang; Ching-Lung Liao; Jen-Jyh Lin; Ming-Jen Fan; Yang-Ching Ko; Yu-Ping Hsiao; Hsu-Feng Lu; Jing-Gung Chung
Journal:  Molecules       Date:  2016-03-19       Impact factor: 4.411

10.  Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex.

Authors:  Liam Baird; David Llères; Sam Swift; Albena T Dinkova-Kostova
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-28       Impact factor: 11.205

View more
  3 in total

1.  Heme oxygenase promotes B-Raf-dependent melanosphere formation.

Authors:  Kimberly J Jasmer; Jie Hou; Philip Mannino; Jianlin Cheng; Mark Hannink
Journal:  Pigment Cell Melanoma Res       Date:  2020-07-09       Impact factor: 4.693

2.  Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma.

Authors:  Monica Argenziano; Federica Bessone; Chiara Dianzani; Marie Angèle Cucci; Margherita Grattarola; Stefania Pizzimenti; Roberta Cavalli
Journal:  Pharmaceutics       Date:  2022-01-31       Impact factor: 6.321

Review 3.  Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.

Authors:  Stefania Pizzimenti; Simone Ribero; Marie Angele Cucci; Margherita Grattarola; Chiara Monge; Chiara Dianzani; Giuseppina Barrera; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2021-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.